ADITYA P. MOHANTY
CIK 1629819 · Chief Executive Officer · last filed 2024-08-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
21
Lifetime Open-Market Net
$18.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIORA THERAPEUTICS, INC. (BIOR) Delisted | Chief Executive Officer | 1,468,609 | $0.22 | $323.1K | $0 | 8 | 2024-08-16 |
| BIORA THERAPEUTICS, INC. (PROG) Delisted | Chief Executive Officer | 1,412,429 | $0.88 | $1.25M | $0 | 1 | 2021-11-15 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | — | $3.20 | — | $0 | 2 | 2019-07-19 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Co-Chief Executive Officer | 103,005 | — | — | $18.8K | 10 | 2018-07-12 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-27 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-12 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Mixed | +3,066 | -$3.6K | EDGAR |
| 2018-04-12 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Mixed | +3,066 | -$4.0K | EDGAR |
| 2018-03-19 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-12 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Mixed | +2,630 | -$5.5K | EDGAR |
| 2017-10-12 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Mixed | +2,926 | -$5.0K | EDGAR |
| 2017-08-22 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | +7,500 | $18.8K | EDGAR |
| 2017-07-12 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Mixed | +2,925 | -$5.4K | EDGAR |
| 2017-06-08 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-01 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Mixed | +11,704 | -$23.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.